Zolpidem Tartrate
Product Images NDC 50090-4479

3 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 50090-4479). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of zolpidem tartrate, showing the molecular arrangement of the active ingredient zolpidem combined with tartrate groups. The diagram includes heterocyclic and aromatic rings and functional groups characteristic of zolpidem tartrate.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph showing mean plasma concentration-time profiles for Zolpidem Tartrate extended-release tablets (12.5 mg) and immediate-release tablets (10 mg). The x-axis represents time in hours (0 to 8), and the y-axis shows zolpidem plasma concentrations in ng/mL (0 to 120). Two curves compare plasma levels over time for the two formulations.*
FDA Label Image

Label Image (Lbl500904479)

Label Image (Lbl500904479)
Zolpidem Tartrate 12.5 mg extended release tablets packaging label from A-S Medication Solutions. The label includes text indicating 30 tablets in the package, each as an extended release dosage form. The label also shows storage instructions and a QR code for dosage information, along with NDC 50090-4479.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.